How UniteRare Brought Rare Disease Information, Treatment Access, and Support Into One AI-Powered Platform
Prismberry partnered with UniteRare to build an end-to-end digital platform for the rare disease community. The solution gives patients, caregivers, and clinicians one place to understand a condition, find FDA-approved treatments, clinical trials, and specialists, explore symptoms with AI assistance, and turn insurance denials into stronger appeals, while giving the UniteRare team an admin console to keep disease data accurate and current.
Patients and caregivers can find disease information, treatments, trials, specialists, and support in a single place instead of searching across many sources.
Alias, abbreviation, and equivalent-name resolution helps users reach the right disease even when they do not know its primary medical name.
AI Diagnosis Assist helps users organise symptoms and prepare better questions, supporting more productive conversations with clinicians.
The Appeals Assistant turns a complex, document-heavy process into a guided workflow for building insurance appeals.
Specialist search, travel grants, and patient assistance programs help families overcome geographic and financial barriers to treatment.
Admin tools and AI-powered data reviews keep thousands of disease records complete and consistent with minimal manual effort.
People living with rare diseases often spend years on a diagnostic odyssey. Information about their condition, available treatments, active research, qualified specialists, and financial support is scattered across many sources, written in clinical language, and difficult to act on. UniteRare needed a single, trustworthy platform that brought these pieces together for patients, caregivers, and…
Prismberry designed and developed UniteRare as a unified web platform that connects authoritative medical data sources with AI-assisted tools in plain-language, guided workflows.
Users can search by primary name, alias, equivalent name, or abbreviation. Every query is resolved to the canonical disease, and a clear “Did you mean” prompt shows when an alternative name was used.
Each disease page brings together definitions, symptoms, affected organs, diagnostic methods, biomarkers, epidemiology, a disease-specific glossary, and AI-generated plain-language summaries.
A weighted relevance-scoring engine matches FDA-approved drugs to each disease, filters out irrelevant categories, and surfaces the most relevant treatments with dosage forms, warnings, and contraindications.
Recruiting and upcoming studies are pulled from ClinicalTrials.gov so patients and clinicians can review research options together.
A guided, multi-step symptom tool lets users enter and refine symptoms, upload supporting documents, save sessions, and receive ranked possible conditions with questions to bring to their clinician.
Users upload denial letters and insurance documents for AI analysis, then work through a guided chat to build stronger, evidence-backed appeals and track each appeal’s status.
A searchable directory of rare disease specialists and centers is complemented by travel and lodging grant search and non-profit and manufacturer patient assistance programs.
Disease-specific news is cached with smart refresh, fallback search, and stale-cache serving to keep content current while controlling API costs.
Curated disease information, treatments, trials, and news brought together in one place.
Symptom exploration and plain-language summaries that support, not replace, clinical advice.
Guided insurance appeals, patient assistance programs, and travel grants that help families get care covered and funded.
Specialist and center discovery alongside patient communities, so no family has to navigate a rare disease alone.
Admin tools, AI data reviews, and role-based access keep information accurate, current, and secure.
Prismberry helps organizations build AI-powered platforms that make complex information accessible, automate document-heavy workflows, and create better digital experiences for patients and caregivers.